L95.1 Erythema elevatum diutinum

Name of the Condition

• Erythema elevatum diutinum

Summary

Erythema elevatum diutinum is a rare, chronic skin condition characterized by persistent, symmetrical, and painful papules, plaques, or nodules. These lesions typically develop on the extensor surfaces of the extremities, such as the elbows, knees, and hands, and may progress to a violaceous or brownish hue over time. The condition is associated with underlying systemic diseases, particularly hematologic or autoimmune disorders, and is thought to result from immune complex deposition in small blood vessels.

Causes

The exact cause of erythema elevatum diutinum is not fully understood, but it is believed to involve immune complex-mediated vasculitis. These immune complexes deposit in the walls of small blood vessels, leading to inflammation and tissue damage. The condition is often linked to underlying conditions such as IgA monoclonal gammopathy, multiple myeloma, or autoimmune diseases like rheumatoid arthritis. In some cases, no underlying cause is identified.

Risk Factors

• Underlying systemic diseases: Conditions like hematologic malignancies, autoimmune disorders, or chronic infections may increase risk.
• Age: Typically affects adults, with a peak incidence in middle age.
• Genetic predisposition: Rare familial cases have been reported, suggesting a possible genetic component.

Symptoms

• Symmetrical, firm, and painful papules, plaques, or nodules on extensor surfaces (e.g., elbows, knees, hands).
• Lesions may be red, violaceous, or brownish and can persist for months or years.
• Pruritus or tenderness at the site of lesions.
• In severe cases, lesions may ulcerate or develop a necrotic center.

Diagnosis

Diagnosis is based on clinical presentation and histopathological examination. A skin biopsy is typically performed to confirm the presence of leukocytoclastic vasculitis with immune complex deposition. Laboratory tests may be ordered to evaluate for underlying systemic conditions, such as serum protein electrophoresis or rheumatoid factor testing. Imaging or other diagnostic studies may be considered if an underlying disease is suspected.

Treatment Options

• Dapsone: The first-line treatment, effective in reducing inflammation and lesions.
• Corticosteroids: Used for severe or refractory cases, either topically or systemically.
• Immunosuppressants: Agents like cyclophosphamide or azathioprine may be considered for resistant cases.
• Management of underlying conditions: Treating associated diseases (e.g., hematologic disorders) can improve skin manifestations.

Prognosis and Follow-Up

The prognosis is generally good with appropriate treatment, though lesions may persist or recur. Long-term follow-up is recommended to monitor for underlying conditions and adjust therapy as needed. Regular skin examinations and laboratory testing may be necessary to assess disease activity and response to treatment.

Complications

• Chronic pain or discomfort from persistent lesions.
• Ulceration or necrosis in severe cases.
• Potential association with systemic diseases, which may require additional management.

Lifestyle & Prevention

• Avoid trauma to affected areas to prevent lesion exacerbation.
• Maintain good skin hygiene to reduce infection risk.
• Manage underlying conditions as directed by a healthcare provider to minimize flare-ups.

When to Seek Professional Help

Seek medical attention if lesions are painful, spreading, or accompanied by systemic symptoms (e.g., fever, fatigue). Prompt evaluation is important if an underlying disease is suspected or if treatment is ineffective.

Tips for Medical Coders

When coding for erythema elevatum diutinum (ICD-10-CM code L95.1), ensure documentation supports the clinical diagnosis, including lesion characteristics, location, and any associated systemic conditions. Note the chronicity and treatment response, as these may impact coding specificity. Verify that the code aligns with the patient’s documented history and current clinical findings.